IM CANNABIS CORP (IMCC)

Company Profile

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company is headquartered in Vancouver, British Columbia and currently employs 153 full-time employees. The company went IPO on 2019-11-05. The firm operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The firm operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The firm operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

Company Info

IM CANNABIS CORP

550 Burrard Street, Suite 2300

Vancouver BRITISH COLUMBIA

P: 14168640578

CEO: Oren Shuster

Employees: 153

Website: https://imcannabis.com/